EP Patent

EP2968267A1 — Anticholinergic glycopyrrolate esters for the treatment of hyperhidrosis

Assigned to Bodor Laboratories Inc · Expires 2016-01-20 · 10y expired

What this patent protects

Use of a compound having the formula (I) in the preparation of a medicament composition comprising from about 1.0% to about 25% of said compound and a pharmaceutically acceptable vehicle, for topical administration to skin of an area of a mammalian subject suffering from hyperhid…

USPTO Abstract

Use of a compound having the formula (I) in the preparation of a medicament composition comprising from about 1.0% to about 25% of said compound and a pharmaceutically acceptable vehicle, for topical administration to skin of an area of a mammalian subject suffering from hyperhidrosis, before bedtime, such that compared to untreated, baseline conditions, sweat production is reduced by at least about 25% for at least about six (6) hours.

Drugs covered by this patent

Patent Metadata

Patent number
EP2968267A1
Jurisdiction
EP
Classification
—
Expires
2016-01-20
Drug substance claim
No
Drug product claim
No
Assignee
Bodor Laboratories Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.